• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Genomics . Species-specific RNA barcoding technology for rapid and accurate identification of four types of influenza virus

tetano

Editor, Senior Moderator
BMC Genomics


. 2025 Apr 28;26(1):409.
doi: 10.1186/s12864-025-11602-0. Species-specific RNA barcoding technology for rapid and accurate identification of four types of influenza virus

Shuai Jiang[SUP] #[/SUP][SUP] 1 [/SUP], Yunyun Ding[SUP] #[/SUP][SUP] 1 [/SUP], Gaili Zhao[SUP] 1 [/SUP], Shunxing Ye[SUP] 2 [/SUP], Shucan Liu[SUP] 1 [/SUP], Yan Yin[SUP] 1 [/SUP], Zeqi Li[SUP] 1 [/SUP], Xiaoxiao Zou[SUP] 1 [/SUP], Daolong Xie[SUP] 1 [/SUP], Changqiao You[SUP] 3 [/SUP], Xinhong Guo[SUP] 4 [/SUP]



Affiliations
Abstract

Background: The influenza virus (IV) is responsible for seasonal flu epidemics. Constant mutation of the virus results in new strains and widespread reinfections across the globe, bringing great challenges to disease prevention and control. Research has demonstrated that barcoding technology efficiently and cost-effectively differentiates closely related species on a large scale. We screened and validated species-specific RNA barcode segments based on the genetic relationships of four types of IVs, facilitating their precise identification in high-throughput sequencing viral samples.
Results: Through the analysis of single nucleotide polymorphism, population genetic characteristics, and phylogenetic relationships in the training set, 7 IVA type, 29 IVB type, 40 IVC type, and 5 IVD type barcode segments were selected. In the testing set, the nucleotide-level recall rate for all barcode segments reached 96.86%, the average nucleotide-level specificity was approximately 55.27%, the precision rate was 100%, and the false omission rate was 0%, demonstrating high accuracy, specificity, and generalization capabilities for species identification. Ultimately, all four types of IVs were visualized in a combination of one-dimensional and two-dimensional codes and stored in an online database named Influenza Virus Barcode Database (FluBarDB, http://virusbarcodedatabase.top/database/index.html ).
Conclusion: This study validates the effective application of RNA barcoding technology in the detection of IVs and establishes criteria and procedures for selecting species-specific molecular markers. These advancements enhance the understanding of the genetic and epidemiological characteristics of IVs and enable rapid responses to viral genetic mutations.

Keywords: Epidemic surveillance; Influenza virus; RNA barcoding technology; Species identification.

 
Back
Top